The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...

Researchers at IISc have developed an enzyme treatment that dismantles biofilms formed by Klebsiella pneumoniae, enhancing the action of antibiotics. Tests on biofilms and infected mice showed ...

A WOMAN who was admitted to hospital with a UTI died after contracting a dangerous new strain of superbug. A strain of the ...

It is indicated to treat uUTIs caused by Escherichia coli, Klebsiella ... said. The treatment is not indicated for primary or step-down treatment of complicated UTI or complicated intra-abdominal ...

In children UTI is usually caused by gram-negative organisms, including Escherichia coli, Klebsiella spp ... were symptomatic and treated with antibiotics. Two of the three children with cystitis ...

Sulopenem, which will now go by the commercial moniker Orlynvah, was approved by the FDA Friday to treat uncomplicated urinary tract infections (uUTIs) caused by E. coli, Klebsiella pneumoniae or ...

for the treatment of uncomplicated urinary tract infections (uUTIs) caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women who have ...

Klebsiella pneumoniae is a bacterium found in a person ... animal model study showing us a mechanism underlying the gut-brain connection. “Antibiotic treatment of gut illnesses can lead to unintended ...

The research utilizes an enzyme derived from a cow's digestive system, presenting potentially transformative implications in medical treatment for stubborn bacterial infections. The study highlights ...

The treatment is not indicated for primary ... Clinical trials evaluating the antibiotic in complicated UTI or complicated intra-abdominal infections did not demonstrate effectiveness, the FDA ...